PSUN188 Evaluating Response to GLP-1 Receptor Agonists in Patients with Type 2 Diabetes Mellitus Managed at a Veterans Affairs Hospital

Type 2 diabetes mellitus (T2DM) is a leading cause of morbidity and mortality in people of all ages worldwide. Glucagon-like peptide-1 receptor agonists (GLP-1 RA) offer an innovative and unique advancement in treatment for T2DM by not only benefiting blood glucose control but also potentially impac...

Descripción completa

Detalles Bibliográficos
Autores principales: Davis, Clifton, Samson, Kaeli, Kunwar, Sandeep, Desouza, Cyrus, Shivaswamy, Vijay
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Diabetes & Glucose Metabolism
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9624607/
http://dx.doi.org/10.1210/jendso/bvac150.778

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9624607/
http://dx.doi.org/10.1210/jendso/bvac150.778

Ejemplares similares